Hiv Vaccine Current Events | Hiv Vaccine News | 11
|
| Page
11 of
63 |
1256 Results |
|
|
|
Sort By:
Page Views | Date |
Transmission of drug-resistant HIV-1
Drug-resistant forms of HIV can be spread between individuals who have not received anti-retroviral treatment. view more (2009-03-30)
Cytomegalovirus infection still associated with poor HIV/AIDS prognosis (p 2101, 2116)
Results of a UK study in this week's issue of THE LANCET highlight how the treatment of cytomegalovirus infection remains a priority in order to improve the prognosis for people with HIV-1 infection, including people already receiving antiretroviral therapy. The advent of highly active antiretroviral therapy (HAART) at the end of the 20th century... view more... (2004-06-23)
Having a stable partner delays AIDS in HIV patients
For people with HIV, having a stable partner is associated with slower rate of progression to AIDS or death, finds a study in this week's BMJ. Researchers in Switzerland followed 3,736 adults with HIV who had started highly active antiretroviral therapy (HAART) before 2002. Every six months, patients were asked whether they had had sexual... view more... (2004-01-03)
Scientists develop fungus-fighting vaccine
group of scientists in Italy have developed a vaccine with the potential to protect against fungal pathogens that commonly infect humans, according to a study by Torosantucci and colleagues in the September 5 issue of The Journal of Experimental Medicine. view more (2005-09-06)
Study suggests life insurance should cover people treated for HIV (p 877)
Issue 13 September 2003 Embargoed 0001 h (London time) 12 September 2003. Authors of a Swiss study in this week's issue of THE LANCET highlight how people effectively treated for HIV-1 infection with highly active antiretroviral therapy (HAART) have similar or lower mortality rates than patients successfully treated for cancer-calling into... view more... (2003-09-10)
Study Suggests Potential Of Low-cost Options For Monitoring Disease Status In Hiv-1-Infected Children In Less-developed Countries (pp 1597, 1625)
Authors of a research letter in this week's issue of THE LANCET highlight how assessment of total blood lymphocyte count and albumen concentrations could have potential as low-cost alternatives in assessing the disease status of HIV-1-infected children in less-developed countries. The cost of laboratory analysis of CD4 lymphocyte count and... view more... (2003-11-12)
Should we test for HIV status in pregnant women?
Dr Lorraine Sherr, Professor Chris Hudson, and colleagues from several UK and European medical schools, have been studying the way other European countries are handling the problem, and found that the major variations between countries reflect the complexity of the ethics involved. view more (1999-06-03)
Routine HIV screening in the ED is cost effective and well liked by patients
Using the new and highly publicized CDC guidelines for HIV screening, a university-based Emergency Department implemented opt-out screening in Washington, DC, where HIV infection rates are known to be high. view more (2007-05-16)
Risk of fracture is significantly higher in HIV-infected patients
As antiviral treatment for HIV infection allows patients to live longer, many will be confronted with additional health challenges. A new study shows for the first time that one of these may be significantly increased risk of bone fractures. view more (2008-08-29)
Combination anti-retroviral therapies associated with reduced infections in HIV-infected children
Since the introduction of highly active antiretroviral therapies, there has been a substantial reduction of opportunistic infections and other infections in HIV-infected children, such as pneumonia and tuberculosis. view more (2006-07-19)
Three out of four junior doctors risk potential HIV infection during course of work
Three out of four junior doctors are at potentially high risk of HIV infection at some time during their careers, shows a survey in Sexually Transmitted Infections. Yet two thirds were unaware that they could be treated immediately afterwards to minimise the risk of infection. view more (2001-11-20)
Malaria may fuel spread of HIV in sub-Saharan Africa
Malaria may be fueling the spread of HIV in areas of sub-Saharan Africa where there is a substantial overlap between the two diseases, while HIV may be playing a role in boosting adult malaria-infection rates in some parts of the region, according to a new study by researchers at Fred Hutchinson Cancer Research Center and the University of... view more... (2006-12-08)
New therapies mean HIV patients gain longer lives, face new challenges
New HIV therapies have prolonged lives and improved health for patients with HIV, but the treatments have also brought the longer-term effects of the disease into sharper focus. view more (2009-05-18)
Engineered killer T cell recognizes HIV-1's lethal molecular disguises
Researchers at the University of Pennsylvania School of Medicine and colleagues in the United Kingdom have engineered T cells able to recognize HIV-1 strains that have evaded the immune system. view more (2008-11-10)
Why were the HIV prevention trials in commercial sex workers abandoned?
One promising approach to help stem the global HIV epidemic is to give commercial sex workers an HIV medication (such as the drug tenofovir) before they have high risk sex in the hope of reducing their chances of becoming infected, an approach called "pre-exposure prophylaxis" (PREP). view more (2005-07-19)
Racing against the clock to distribute H1N1 flu vaccine
Drug companies are sprinting ahead in a race against the clock to deliver millions of doses of vaccine for the H1N1 influenza virus before cooler weather ushers in the 2009-2010 flu season. view more (2009-10-01)
Breastfeeding now safer for infants of HIV-infected mothers
An antiretroviral drug already in widespread use in the developing world to prevent the transmission of HIV from infected mothers to their newborns during childbirth has also been found to substantially cut the risk of subsequent HIV transmission during breast-feeding. view more (2008-02-05)
HIV: a sugar shield to evade host defences
In humans, the Aids virus HIV manifests extreme genetic variability. It is particularly virulent, probably because its introduction into populations is recent (2). It has a potential for rapid evolution, at both population and individual scales, owing to a mutation rate among the highest in the living world, and to its recombination capacity. This... view more... (2004-04-15)
Who should receive vaccines and antiviral drugs in the event of a flu pandemic?
Since flu vaccine and antiviral drugs are in scarce supply, the WHO recommends that all nations determine in advance which groups of people will be the first to receive these treatments in the event of a flu pandemic. view more (2006-10-17)
Vaccinate infants of hepatitis B mothers, say experts
Immunising newborn infants of mothers with hepatitis B prevents infection being transmitted from mother to child, finds a study published online by the BMJ today. view more (2006-01-27)
|
|
| Page
11 of
63 |
1256 Results |
|
|
|
Sort By:
Page Views | Date |
|
